Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

IDT Australia Ltd

IDT.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Biotechnology & Medical Research ·

Australia Micro Cap Analyst: N/A

Last Close

$0.03

▼ -6.38%

Market Cap $13.26M · Vol 200.24K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$13.26M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

66.67

Momentum

Beta

1.43

vs Market

52W High

$0.05

33.33% below

52W Low

$0.02

46.87% above

Volume

200.24K

Avg 179.76K

P/B

1.75

Price-to-book

ROE

N/A

Return on equity

Free Float

80.64%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, IDT Australia Ltd (IDT.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does IDT.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-8.33%

+37.50%

+15.79%

-8.33%

YTD

-13.73%

-39.73%

-24.90%

-89.24%

Financials & Valuation

TTM · Annual

Total Revenue	$13.07M
Net Income	$-5,305,443.00
Revenue Growth (YoY)	-7.05%
Gross Margin	64.86%
Operating Margin	-36.78%
Net Profit Margin	-40.60%
ROE	N/A
ROA · ROIC	-23.61% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.92
P/B	1.75
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	427.26M

Technical Indicators

50-Day SMA	$0.03
200-Day SMA	$0.03
RSI (14)	66.67
Beta	1.43
52-Week High	$0.05
52-Week Low	$0.02

Volume Today	200.24K
Avg Daily Volume (30D)	179.76K
Relative Volume	1.11x
Volatility (10D)	94.60
Volatility (30D)	111.67
Free Float	80.64%

Analyst Consensus

N/A

Current Price $0.03

Mean Target N/A

52W Low$0.02 52W High$0.05

Current

Target

$0.02 $0.05

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG001S6MQM7

ISINAU000000IDT0

CountryAustralia

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

IDT Australia Limited is a pharmaceutical manufacturing company. The Company is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. Its business includes research and development, active pharmaceutical ingredient (API) and finished dosage form manufacture (FDF), clinical and commercial, project management, chemical services, analytical chemistry, pharmacy services, pharmaceutical development in all dosage forms, clinical packaging and regulatory affairs services. Its Current Good Manufacturing Practice (cGMP) manufacturing facilities produces both API and FDF across the medicinal cannabis manufacturing space. It also provides a full-scale service for new drug development and scale-up, commercial active drug manufacture as well as a variety of oral and injectable finished drug dose forms. Its analytical laboratories offer medicinal cannabis cGMP testing.